APA (7th ed.) Citation

H, F., K, S., M, N., Y, K., Y, M., N, O., . . . W, O. (2026). Clinical utility of the MAF-5 score for assessing MAFLD/MASLD in a Japanese population with obesity. Diabetology international, 17(1), 19. https://doi.org/10.1007/s13340-025-00874-2

Chicago Style (17th ed.) Citation

H, Fukumitsu, et al. "Clinical Utility of the MAF-5 Score for Assessing MAFLD/MASLD in a Japanese Population with Obesity." Diabetology International 17, no. 1 (2026): 19. https://doi.org/10.1007/s13340-025-00874-2.

MLA (9th ed.) Citation

H, Fukumitsu, et al. "Clinical Utility of the MAF-5 Score for Assessing MAFLD/MASLD in a Japanese Population with Obesity." Diabetology International, vol. 17, no. 1, 2026, p. 19, https://doi.org/10.1007/s13340-025-00874-2.